In a move that took the PACS industry by surprise, eMed Technologies announced May 17 the resignation of CEO Caren Mason. The company cited Mason’s long-distance commute from Wisconsin to eMed’s Boston-based headquarters and her
In a move that took the PACS industry by surprise, eMed Technologies announced May 17 the resignation of CEO Caren Mason. The company cited Mason’s long-distance commute from Wisconsin to eMed’s Boston-based headquarters and her responsibilities to family as reasons for her resignation. Since taking the helm in January 2000, Mason led eMed to an improved position within the PACS and networking marketplace. She also bolstered corporate finances by securing $22 million dollars in venture capital investment. The company’s board of directors has initiated a search for Mason’s replacement.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.